C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Name: C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
SKU: 3369
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 1 Articles Tags: c-lindsay-devane, dosage-regimen-design, heidi-l-liston, medworks-media, pharmacokinetics, psychopharmacology, psychopharmacology-bulletin, second-dose-effect

Description

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology

C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD

Related products

Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3